+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneus Ltd - logo

Founded in 2007, Regeneus are a Sydney-based regenerative medicine company developing a portfolio of innovative cell-based therapies, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms.The company has two product candidates in Phase 1 trials for humans, Progenza and RGSH4K. Regeneus is headquartered in New South Wales, Australia.

From
Stem Cell Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Stem Cell Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 100 Pages
  • Global
From
Cell Therapy Biomanufacturing: Global Markets - Product Thumbnail Image

Cell Therapy Biomanufacturing: Global Markets

  • Report
  • February 2021
  • 112 Pages
  • Global
From
From
Stem Cell Therapy Contract Manufacturing Market, 2019-2030 - Product Thumbnail Image

Stem Cell Therapy Contract Manufacturing Market, 2019-2030

  • Report
  • August 2019
  • 320 Pages
  • Global
From
From
From
From
From
From
From
Burns (Dermatology) - Drugs In Development, 2021 - Product Thumbnail Image

Burns (Dermatology) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 142 Pages
  • Global
From
Loading Indicator